1. Home
  2. WFCF vs CUE Comparison

WFCF vs CUE Comparison

Compare WFCF & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WFCF

Where Food Comes From Inc.

N/A

Current Price

$13.15

Market Cap

59.1M

Sector

Technology

ML Signal

N/A

Logo Cue Biopharma Inc.

CUE

Cue Biopharma Inc.

HOLD

Current Price

$0.49

Market Cap

49.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WFCF
CUE
Founded
1996
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
59.1M
49.6M
IPO Year
2011
2018

Fundamental Metrics

Financial Performance
Metric
WFCF
CUE
Price
$13.15
$0.49
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$3.00
AVG Volume (30 Days)
3.7K
387.5K
Earning Date
11-13-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
45.82
N/A
EPS
0.53
N/A
Revenue
$25,512,000.00
$7,100,000.00
Revenue This Year
N/A
$36.58
Revenue Next Year
N/A
$32.10
P/E Ratio
$24.82
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.26
$0.48
52 Week High
$13.78
$1.75

Technical Indicators

Market Signals
Indicator
WFCF
CUE
Relative Strength Index (RSI) 60.00 28.20
Support Level $12.50 $0.55
Resistance Level $13.15 $0.66
Average True Range (ATR) 0.42 0.05
MACD 0.13 -0.00
Stochastic Oscillator 100.00 10.69

Price Performance

Historical Comparison
WFCF
CUE

About WFCF Where Food Comes From Inc.

Where Food Comes From Inc is a third-party food verification company. It offers food production audits and uses verification processes to ensure that claims made by food producers and processors are accurate. The company supports farmers, ranchers, vineyards, wineries, processors, retailers, distributors, trade associations, and restaurants with a wide variety of value-added services provided through its family of verifiers, including International Certification Services, Validus Verification Services, and others. The company operates in two segments that are verification and certification and Software Sales and Related Consulting. It generates the majority of its revenue from verification and certification.

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

Share on Social Networks: